SARS vaccine development: caution versus urgency

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	Animal Model Testing Procedure Vaccine Candidate Animal Test Stringent Condition

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1426(2004), 1 vom: Feb., Seite 3-3
Übergeordnetes Werk:	volume:1426 ; year:2004 ; number:1 ; month:02 ; pages:3-3

Links:	Volltext

DOI / URN:	10.2165/00128413-200414260-00005

Katalog-ID:	SPR035180358

Internformat


LEADER	01000caa a22002652 4500
001	SPR035180358
003	DE-627
005	20230519235329.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414260-00005 \|2 doi
035			\|a (DE-627)SPR035180358
035			\|a (SPR)00128413-200414260-00005-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a SARS vaccine development: caution versus urgency
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a Animal Model \|7 (dpeaa)DE-He213
650		4	\|a Testing Procedure \|7 (dpeaa)DE-He213
650		4	\|a Vaccine Candidate \|7 (dpeaa)DE-He213
650		4	\|a Animal Test \|7 (dpeaa)DE-He213
650		4	\|a Stringent Condition \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1426(2004), 1 vom: Feb., Seite 3-3 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1426 \|g year:2004 \|g number:1 \|g month:02 \|g pages:3-3
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414260-00005 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1426 \|j 2004 \|e 1 \|c 02 \|h 3-3

Indexfelder

matchkey_str	article:22306056:2004----::asacndvlpetatov
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414260-00005 doi (DE-627)SPR035180358 (SPR)00128413-200414260-00005-e DE-627 ger DE-627 rakwb eng SARS vaccine development: caution versus urgency 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1426(2004), 1 vom: Feb., Seite 3-3 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1426 year:2004 number:1 month:02 pages:3-3 https://dx.doi.org/10.2165/00128413-200414260-00005 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1426 2004 1 02 3-3
spelling	10.2165/00128413-200414260-00005 doi (DE-627)SPR035180358 (SPR)00128413-200414260-00005-e DE-627 ger DE-627 rakwb eng SARS vaccine development: caution versus urgency 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1426(2004), 1 vom: Feb., Seite 3-3 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1426 year:2004 number:1 month:02 pages:3-3 https://dx.doi.org/10.2165/00128413-200414260-00005 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1426 2004 1 02 3-3
allfields_unstemmed	10.2165/00128413-200414260-00005 doi (DE-627)SPR035180358 (SPR)00128413-200414260-00005-e DE-627 ger DE-627 rakwb eng SARS vaccine development: caution versus urgency 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1426(2004), 1 vom: Feb., Seite 3-3 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1426 year:2004 number:1 month:02 pages:3-3 https://dx.doi.org/10.2165/00128413-200414260-00005 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1426 2004 1 02 3-3
allfieldsGer	10.2165/00128413-200414260-00005 doi (DE-627)SPR035180358 (SPR)00128413-200414260-00005-e DE-627 ger DE-627 rakwb eng SARS vaccine development: caution versus urgency 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1426(2004), 1 vom: Feb., Seite 3-3 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1426 year:2004 number:1 month:02 pages:3-3 https://dx.doi.org/10.2165/00128413-200414260-00005 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1426 2004 1 02 3-3
allfieldsSound	10.2165/00128413-200414260-00005 doi (DE-627)SPR035180358 (SPR)00128413-200414260-00005-e DE-627 ger DE-627 rakwb eng SARS vaccine development: caution versus urgency 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1426(2004), 1 vom: Feb., Seite 3-3 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1426 year:2004 number:1 month:02 pages:3-3 https://dx.doi.org/10.2165/00128413-200414260-00005 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1426 2004 1 02 3-3
language	English
source	Enthalten in Inpharma weekly 1426(2004), 1 vom: Feb., Seite 3-3 volume:1426 year:2004 number:1 month:02 pages:3-3
sourceStr	Enthalten in Inpharma weekly 1426(2004), 1 vom: Feb., Seite 3-3 volume:1426 year:2004 number:1 month:02 pages:3-3
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Animal Model Testing Procedure Vaccine Candidate Animal Test Stringent Condition
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-02-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035180358
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035180358</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235329.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414260-00005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035180358</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414260-00005-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">SARS vaccine development: caution versus urgency</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal Model</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Testing Procedure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccine Candidate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal Test</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Stringent Condition</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1426(2004), 1 vom: Feb., Seite 3-3</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1426</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:3-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414260-00005</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1426</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">3-3</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	SARS vaccine development: caution versus urgency Animal Model (dpeaa)DE-He213 Testing Procedure (dpeaa)DE-He213 Vaccine Candidate (dpeaa)DE-He213 Animal Test (dpeaa)DE-He213 Stringent Condition (dpeaa)DE-He213
topic	misc Animal Model misc Testing Procedure misc Vaccine Candidate misc Animal Test misc Stringent Condition
spellingShingle	misc Animal Model misc Testing Procedure misc Vaccine Candidate misc Animal Test misc Stringent Condition SARS vaccine development: caution versus urgency
topic_unstemmed	misc Animal Model misc Testing Procedure misc Vaccine Candidate misc Animal Test misc Stringent Condition
topic_browse	misc Animal Model misc Testing Procedure misc Vaccine Candidate misc Animal Test misc Stringent Condition
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	SARS vaccine development: caution versus urgency
ctrlnum	(DE-627)SPR035180358 (SPR)00128413-200414260-00005-e
title_full	SARS vaccine development: caution versus urgency
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	3
container_volume	1426
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414260-00005
title_sort	sars vaccine development: caution versus urgency
title_auth	SARS vaccine development: caution versus urgency
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	SARS vaccine development: caution versus urgency
url	https://dx.doi.org/10.2165/00128413-200414260-00005
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414260-00005
up_date	2024-07-03T13:48:49.651Z
_version_	1803565955450667008
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035180358</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235329.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414260-00005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035180358</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414260-00005-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">SARS vaccine development: caution versus urgency</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal Model</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Testing Procedure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccine Candidate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Animal Test</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Stringent Condition</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1426(2004), 1 vom: Feb., Seite 3-3</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1426</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:3-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414260-00005</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1426</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">3-3</subfield></datafield></record></collection>
score	7.4021854

Nicht das Richtige dabei?

Schreiben Sie uns!

SARS vaccine development: caution versus urgency

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?